PHASE II RANDOMIZED TRIAL OF IVIG WITH OR WITHOUT CYCLOPHOSPHAMIDE IN PEMPHIGUS

$331,059R01FY2009FDFDA

New York University School Of Medicine, New York NY

Investigators

Jean-Claude Bystryncontact

Linked publications & trials

Paper 21923613 Paper 21716321 Paper 20692723 Paper 19075146 Paper 18490602 Paper 18490594 Paper 18423257

View original record on NIH RePORTER →